APYX RSI Chart
Last 7 days
16.9%
Last 30 days
12.9%
Last 90 days
-34.1%
Trailing 12 Months
-52.3%
Historical Charts for Stock Metrics
Year | Q1 | Q2 | Q3 | Q4 |
---|---|---|---|---|
2024 | 50.5M | 0 | 0 | 0 |
2023 | 44.2M | 47.4M | 50.3M | 52.3M |
2022 | 52.4M | 51.4M | 48.7M | 44.5M |
2021 | 31.4M | 38.3M | 43.2M | 48.5M |
2020 | 27.6M | 25.3M | 24.6M | 27.7M |
2019 | 18.8M | 21.8M | 25.7M | 28.2M |
2018 | 12.0M | 13.4M | 14.4M | 16.6M |
2017 | 30.5M | 23.5M | 16.1M | 10.2M |
2016 | 31.2M | 33.2M | 35.4M | 36.6M |
2015 | 27.3M | 27.7M | 28.7M | 29.5M |
2014 | 8.0M | 14.4M | 20.8M | 27.7M |
2013 | 26.6M | 25.2M | 13.4M | 1.6M |
2012 | 26.0M | 26.6M | 27.0M | 27.7M |
2011 | 24.8M | 25.7M | 25.5M | 25.4M |
2010 | 0 | 26.0M | 25.1M | 24.2M |
2009 | 0 | 0 | 0 | 27.0M |
Datesorted ascending | Name | Buy/Sell | $ Value | Avg. Price | # Shares | Title |
---|---|---|---|---|---|---|
Dec 12, 2023 | hill matthew c | bought | 5,475 | 2.19 | 2,500 | chief financial officer |
Nov 14, 2023 | goodwin charles d. ii | bought | 78,500 | 1.57 | 50,000 | chief executive officer |
Jul 12, 2023 | waldman lawrence | acquired | 15,853 | 2.97 | 5,338 | - |
Jun 26, 2023 | hornsby todd | acquired | 26,550 | 1.77 | 15,000 | executive vice president |
Jun 26, 2023 | hornsby todd | sold | -113,400 | 7.56 | -15,000 | executive vice president |
Jun 06, 2023 | geraghty michael | acquired | 27,900 | 2.79 | 10,000 | - |
Aug 29, 2022 | goodwin charles d. ii | bought | 70,067 | 5.96319 | 11,750 | chief executive officer |
Jul 11, 2022 | citronowicz moshe | acquired | 76,200 | 2.54 | 30,000 | sr. v.p. of operations |
Which funds bought or sold APYX recently?
View All DetailsDatesorted ascending | Fund Name | Type | % Chg | $ Change | $ Held | % Portfolio |
---|---|---|---|---|---|---|
May 10, 2024 | WELLS FARGO & COMPANY/MN | added | 1.29 | -288 | 321 | -% |
May 10, 2024 | DIMENSIONAL FUND ADVISORS LP | reduced | -23.87 | -553,373 | 361,565 | -% |
May 10, 2024 | OSAIC HOLDINGS, INC. | reduced | -77.83 | -26,139 | 3,400 | -% |
May 10, 2024 | JPMORGAN CHASE & CO | reduced | -91.49 | -2,061 | 95.00 | -% |
May 10, 2024 | GROUP ONE TRADING, L.P. | unchanged | - | -4,721 | 5,096 | -% |
May 10, 2024 | BlackRock Inc. | added | 0.4 | -624,180 | 679,414 | -% |
May 10, 2024 | VANGUARD GROUP INC | unchanged | - | -1,865,910 | 2,014,000 | -% |
May 09, 2024 | ProVise Management Group, LLC | unchanged | - | -17,008 | 18,359 | -% |
May 09, 2024 | Kingsview Wealth Management, LLC | added | 156 | 10,535 | 42,198 | -% |
May 09, 2024 | RHUMBLINE ADVISERS | unchanged | - | -1,618 | 1,746 | -% |
Unveiling Apyx Medical Corp's Major ShareHolders
Date Filed | Name of Filer | Percent of Class | No. of Shares | Form Type | |
---|---|---|---|---|---|
Peers (Alternatives to Apyx Medical Corp)
Name | Mkt Capsorted ascending | Revenue | Price %, 1M | Returns, 1Y | P/E | P/S | Rev 1-Yr | Inc 1-Yr |
---|---|---|---|---|---|---|---|---|
LARGE-CAP | ||||||||
ABT | 182.3B | 40.3B | 32.4 | 4.52 | ||||
BDX | 68.5B | 19.7B | 51.38 | 3.47 | ||||
ALGN | 20.5B | 3.9B | 44.42 | 5.24 | ||||
BAX | 18.0B | 14.9B | 6.81 | 1.21 | ||||
MID-CAP | ||||||||
ATR | 9.8B | 3.5B | 31.45 | 2.78 | ||||
HSIC | 9.4B | 12.5B | 24.14 | 0.75 | ||||
BIO | 8.1B | 2.6B | -25.25 | 3.13 | ||||
XRAY | 5.8B | 3.9B | -62.53 | 1.48 | ||||
AXNX | 3.4B | 387.1M | -215.92 | 8.89 | ||||
PDCO | 2.3B | 6.6B | 11.71 | 0.35 | ||||
SMALL-CAP | ||||||||
AHCO | 1.3B | 3.2B | -1.82 | 0.39 | ||||
ANIK | 379.6M | 169.3M | -4.94 | 2.24 | ||||
ANGO | 245.1M | 324.0M | -1.27 | 0.76 | ||||
APYX | 52.0M | 50.5M | -2.28 | 1.03 | ||||
AEMD | 3.1M | 3.7M | -0.25 | 0.82 |
Apyx Medical Corp News
Income Statement (Quarterly) | ||||||||||||||||||||||
Description | (%) Q/Q | 2024Q1 | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 |
Revenue | -30.1% | 10,244,000 | 14,662,000 | 11,976,000 | 13,569,000 | 12,142,000 | 12,611,000 | 9,114,000 | 10,292,000 | 12,493,000 | 16,824,000 | 11,831,000 | 11,224,000 | 8,638,000 | 11,464,000 | 6,954,000 | 4,296,000 | 4,997,000 | 8,382,000 | 7,575,000 | 6,649,000 | 5,629,000 |
Gross Profit | -33.4% | 5,949,000 | 8,929,000 | 7,978,000 | 9,279,000 | 7,573,000 | 8,241,000 | 5,757,000 | 6,914,000 | 8,219,000 | 12,151,000 | 8,056,000 | 7,534,000 | 5,860,000 | 7,701,000 | 4,725,000 | 2,094,000 | 2,984,000 | 5,563,000 | 5,294,000 | 4,674,000 | 3,563,000 |
Operating Expenses | -14.6% | 12,564,000 | 14,705,000 | 12,615,000 | 13,206,000 | 13,184,000 | 14,174,000 | 11,539,000 | 12,890,000 | 14,090,000 | 13,843,000 | 12,024,000 | 11,577,000 | 10,605,000 | 9,754,000 | 9,096,000 | 8,261,000 | 10,476,000 | 11,524,000 | 10,050,000 | 9,096,000 | 9,293,000 |
S&GA Expenses | -27.2% | 4,897,000 | 6,724,000 | 4,841,000 | 5,378,000 | 5,255,000 | 5,809,000 | 4,671,000 | 4,539,000 | 5,465,000 | 6,021,000 | 4,611,000 | 4,261,000 | 3,724,000 | 2,996,000 | 2,706,000 | 2,189,000 | 3,796,000 | 3,870,000 | 3,836,000 | 3,037,000 | 2,957,000 |
R&D Expenses | 11.9% | 1,397,000 | 1,248,000 | 1,276,000 | 1,199,000 | 1,121,000 | 1,255,000 | 1,061,000 | 1,070,000 | 1,158,000 | 947,000 | 1,175,000 | 1,084,000 | 1,115,000 | 918,000 | 1,047,000 | 975,000 | 980,000 | 1,097,000 | 1,016,000 | 888,000 | 730,000 |
EBITDA Margin | -7.3% | -0.37 | -0.35 | -0.31 | -0.36 | -0.49 | -0.49 | -0.37 | -0.32 | -0.29 | -0.29 | -0.32 | -0.37 | - | - | - | - | - | - | - | - | - |
Interest Expenses | 25.1% | 1,396,000 | 1,116,000 | 585,000 | 543,000 | 234,000 | 3,000 | 1,000 | 3,000 | 8,000 | 1,000 | 3,000 | 2,000 | 4,000 | 7,000 | 25,000 | 8,000 | 6,000 | 8,000 | - | - | - |
Income Taxes | -39.1% | 53,000 | 87,000 | -318,000 | 66,000 | -2,267,000 | 151,000 | 50,000 | 96,000 | 70,000 | 134,000 | 73,000 | 107,000 | 66,000 | -391,000 | -715,000 | -1,492,000 | -4,905,000 | -383,000 | 171,000 | 76,000 | 6,000 |
Earnings Before Taxes | 21.0% | -7,537,000 | -9,537,000 | -4,993,000 | -953,000 | -5,799,000 | -5,914,000 | -5,745,000 | -5,354,000 | -5,898,000 | -1,876,000 | -4,161,000 | -3,944,000 | -4,839,000 | -1,922,000 | -4,449,000 | -6,182,000 | -6,856,000 | -5,816,000 | -4,199,000 | -4,219,000 | -5,602,000 |
EBT Margin | -12.2% | -0.46 | -0.41 | -0.35 | -0.39 | -0.52 | -0.51 | -0.39 | -0.34 | -0.30 | -0.31 | -0.34 | -0.40 | - | - | - | - | - | - | - | - | - |
Net Income | 21.1% | -7,576,000 | -9,607,000 | -4,629,000 | -994,000 | -3,483,000 | -6,049,000 | -5,764,000 | -5,426,000 | -5,945,000 | -2,003,000 | -4,222,000 | -4,046,000 | -4,901,000 | -1,527,000 | -3,728,000 | -4,690,000 | -1,951,000 | -5,433,000 | -4,370,000 | -4,295,000 | -5,608,000 |
Net Income Margin | -26.5% | -0.45 | -0.36 | -0.30 | -0.34 | -0.47 | -0.52 | -0.39 | -0.34 | -0.31 | -0.31 | -0.34 | -0.37 | - | - | - | - | - | - | - | - | - |
Free Cashflow | -182.6% | -6,376,000 | -2,256,000 | 3,489,000 | -4,975,000 | -1,991,000 | -4,672,000 | -5,548,000 | -6,273,000 | -4,797,000 | -118,000 | -3,775,000 | -5,035,000 | - | - | - | - | - | - | - | - | - |
Balance Sheet | ||||||||||||||||||||||
Description | (%) Q/Q | 2024Q1 | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 |
Assets | -10.8% | 71.00 | 79.00 | 59.00 | 62.00 | 57.00 | 52.00 | 55.00 | 59.00 | 63.00 | 69.00 | 68.00 | 70.00 | 71.00 | 74.00 | 75.00 | 78.00 | 82.00 | 85.00 | 87.00 | 89.00 | 92.00 |
Current Assets | -12.0% | 62.00 | 70.00 | 50.00 | 53.00 | 53.00 | 43.00 | 46.00 | 51.00 | 55.00 | 61.00 | 60.00 | 62.00 | 63.00 | 66.00 | 68.00 | 70.00 | 74.00 | 77.00 | 79.00 | 82.00 | 85.00 |
Cash Equivalents | -14.6% | 37.00 | 44.00 | 22.00 | 19.00 | 16.00 | 10.00 | 15.00 | 20.00 | 26.00 | 31.00 | 31.00 | 35.00 | 40.00 | 42.00 | 44.00 | 46.00 | 51.00 | 59.00 | 62.00 | 67.00 | 32.00 |
Inventory | -1.3% | 10.00 | 10.00 | 11.00 | 11.00 | 11.00 | 12.00 | 12.00 | 10.00 | 7.00 | 7.00 | 6.00 | 5.00 | 4.00 | 4.00 | 5.00 | 5.00 | 6.00 | 5.00 | 7.00 | 6.00 | 6.00 |
Net PPE | -7.1% | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | 7.00 | 7.00 | 7.00 | 7.00 | 7.00 | 6.00 | 6.00 | 7.00 | 7.00 | 6.00 | 6.00 | 7.00 | 7.00 | 7.00 | 6.00 | 6.00 |
Liabilities | -4.0% | 50.00 | 52.00 | 26.00 | 26.00 | 21.00 | 14.00 | 13.00 | 13.00 | 13.00 | 15.00 | 13.00 | 12.00 | 11.00 | 10.00 | 11.00 | 11.00 | 12.00 | 13.00 | 10.00 | 8.00 | 9.00 |
Current Liabilities | -17.1% | 11.00 | 13.00 | 10.00 | 19.00 | 19.00 | 12.00 | 11.00 | 11.00 | 12.00 | 13.00 | 12.00 | 11.00 | 10.00 | 9.00 | 10.00 | 10.00 | 11.00 | 12.00 | 9.00 | 8.00 | 9.00 |
Long Term Debt | 0.7% | 33.00 | 33.00 | 9.00 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
LT Debt, Current | - | - | - | - | 9.00 | 9.00 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
LT Debt, Non Current | -100.0% | - | 33.00 | 9.00 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Shareholder's Equity | -23.4% | 20.00 | 27.00 | 33.00 | 37.00 | 36.00 | 38.00 | 42.00 | 46.00 | 50.00 | 54.00 | 55.00 | 58.00 | 60.00 | 64.00 | 64.00 | 67.00 | 70.00 | 71.00 | 76.00 | 79.00 | 83.00 |
Retained Earnings | -13.9% | -62.02 | -54.45 | -44.84 | -40.21 | -39.22 | -35.73 | -29.69 | -23.92 | -18.50 | -12.55 | -10.55 | -6.33 | -2.28 | 3.00 | 4.00 | 8.00 | 13.00 | 15.00 | 20.00 | 24.00 | 29.00 |
Additional Paid-In Capital | 1.4% | 82.00 | 81.00 | 78.00 | 77.00 | 75.00 | 73.00 | 72.00 | 70.00 | 68.00 | 66.00 | 65.00 | 64.00 | 62.00 | 61.00 | 60.00 | 59.00 | 58.00 | 57.00 | 56.00 | 55.00 | 54.00 |
Accumulated Depreciation | 3.4% | 4.00 | 4.00 | - | - | 3.00 | 5.00 | 5.00 | 5.00 | 5.00 | 5.00 | 5.00 | 5.00 | 5.00 | 5.00 | 5.00 | 5.00 | 5.00 | 4.00 | - | - | - |
Shares Outstanding | 0.0% | 35.00 | 35.00 | 35.00 | 35.00 | 35.00 | 35.00 | 35.00 | 34.00 | 34.00 | 34.00 | 34.00 | 34.00 | - | - | - | - | - | - | - | - | - |
Minority Interest | -6.3% | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | - | - | - | - | - | - |
Float | - | - | - | - | 168 | - | - | - | 202 | - | - | - | 354 | - | - | - | 190 | - | - | - | 227 | - |
Cashflow (Quarterly) | ||||||||||||||||||||||
Description | (%) Q/Q | 2024Q1 | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 |
Cashflow From Operations | -193.2% | -6,341 | -2,163 | 3,663 | -4,819 | -1,881 | -4,530 | -5,360 | -5,872 | -4,518 | 214 | -3,605 | -5,006 | -2,052 | -1,017 | -2,616 | -5,026 | -7,407 | -3,251 | -4,549 | -5,586 | -5,089 |
Share Based Compensation | 23.4% | 1,128 | 914 | 1,351 | 1,482 | 1,367 | 1,641 | 1,692 | 1,714 | 1,650 | 1,341 | 1,184 | 1,369 | 1,194 | 1,001 | 1,063 | 1,097 | 1,049 | 987 | 543 | 856 | 1,195 |
Cashflow From Investing | 62.4% | -35.00 | -93.00 | -174 | 7,111 | -110 | -142 | -188 | -401 | -279 | -332 | -170 | -29.00 | -192 | -388 | -9.00 | -94.00 | -90.00 | -225 | -558 | 40,483 | 20,841 |
Cashflow From Financing | -100.0% | -5.00 | 23,844 | 164 | 46.00 | 8,112 | -10.00 | 127 | 2.00 | 98.00 | -39.00 | -33.00 | 157 | -61.00 | -134 | 109 | -63.00 | 15.00 | -5.00 | 37.00 | 48.00 | 67.00 |
CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) shares in Thousands, $ in Thousands | 12 Months Ended | |
---|---|---|
Dec. 31, 2023 | Dec. 31, 2022 | |
Income Statement [Abstract] | ||
Sales | $ 52,349 | $ 44,510 |
Cost of sales | 18,590 | 15,379 |
Gross profit | 33,759 | 29,131 |
Other costs and expenses: | ||
Research and development | 4,844 | 4,544 |
Professional services | 7,031 | 9,044 |
Salaries and related costs | 19,637 | 18,621 |
Selling, general and administrative | 22,198 | 20,484 |
Total other costs and expenses | 53,710 | 52,693 |
Gain on sale-leaseback | 2,692 | 0 |
Loss from operations | (17,259) | (23,562) |
Interest income | 921 | 157 |
Interest expense | (2,478) | (15) |
Other income, net | 622 | 509 |
Loss on extinguishment of debt | (3,088) | 0 |
Total other (loss) income, net | (4,023) | 651 |
Loss from operations before income taxes | (21,282) | (22,911) |
Income tax (benefit) expense | (2,432) | 367 |
Net loss | (18,850) | (23,278) |
Net loss attributable to non-controlling interest | (137) | (94) |
Net loss attributable to stockholders | $ (18,713) | $ (23,184) |
Loss per share - basic (in dollars per share) | $ (0.54) | $ (0.67) |
Loss per share - diluted (in dollars per share) | $ (0.54) | $ (0.67) |
Weighted average number of shares outstanding - basic (in shares) | 34,622 | 34,516 |
Weighted average number of shares outstanding - dilutive (in shares) | 34,622 | 34,516 |
CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands | Dec. 31, 2023 | Dec. 31, 2022 |
---|---|---|
Current assets: | ||
Cash and cash equivalents | $ 43,652 | $ 10,192 |
Trade accounts receivable, net of allowance of $608 and $668 | 14,023 | 10,602 |
Income tax receivables | 0 | 7,545 |
Other receivables | 30 | 99 |
Inventories, net of provision for obsolescence of $875 and $457 | 9,923 | 11,797 |
Prepaid expenses and other current assets | 2,734 | 2,737 |
Total current assets | 70,362 | 42,972 |
Property and equipment, net | 1,915 | 6,761 |
Operating lease right-of-use assets | 5,162 | 710 |
Finance lease right-of-use assets | 69 | 115 |
Other assets | 1,732 | 1,217 |
Total assets | 79,240 | 51,775 |
Current liabilities: | ||
Accounts payable | 2,712 | 2,669 |
Accrued expenses and other current liabilities | 9,661 | 8,928 |
Current portion of operating lease liabilities | 347 | 216 |
Current portion of finance lease liabilities | 20 | 37 |
Total current liabilities | 12,740 | 11,850 |
Long-term debt, net of debt discounts and issuance costs | 33,185 | 0 |
Long-term operating lease liabilities | 4,896 | 470 |
Long-term finance lease liabilities | 53 | 73 |
Long-term contract liabilities | 1,246 | 1,408 |
Other liabilities | 198 | 181 |
Total liabilities | 52,318 | 13,982 |
Commitments and Contingencies (Note 17) | ||
EQUITY | ||
Preferred Stock, $0.001 par value; 10,000,000 shares authorized; 0 issued and outstanding as of December 31, 2023 and 2022 | 0 | 0 |
Common stock, $0.001 par value; 75,000,000 shares authorized; 34,643,888 issued and outstanding as of December 31, 2023, and 34,597,822 issued and outstanding as of December 31, 2022 | 35 | 35 |
Additional paid-in capital | 81,114 | 73,282 |
Accumulated deficit | (54,448) | (35,735) |
Total stockholders' equity | 26,701 | 37,582 |
Non-controlling interest | 221 | 211 |
Total equity | 26,922 | 37,793 |
Total liabilities and equity | $ 79,240 | $ 51,775 |